Add this result to my export selection LITHIUM CARBONATE | Drug Source: British National Formulary - BNF (Remove filter) 11 February 2021 Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for LITHIUM CARBONATE. Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection LITHIUM CARBONATE | Medicinal forms Source: British National Formulary - BNF (Remove filter) 11 February 2021 LITHIUM CARBONATE Tablet Modified-release tablet Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection Medicines that you cannot export from the UK or hoard Source: GOV UK (Add filter) Source: Department of Health (Remove filter) 22 December 2020 Sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK patients. Type: Policy and Strategy (Remove filter)
Add this result to my export selection Obesity | Treatment summary Source: British National Formulary - BNF (Remove filter) 11 February 2021 drugs, insulin (when used in the treatment of type 2 diabetes), lithium carbonate, lithium citrate, sodium valproate,... Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology (PDF) Source: British Association for Psychopharmacology - BAP (Remove filter) Published by British Association for Psychopharmacology, 11 December 2019 These updated guidelines from the British Association for Psychopharmacology replace the original version published in 2011. They address the scope and targets of pharmacological treatment for... Read Summary Type: Guidance (Remove filter)
Add this result to my export selection BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP (PDF) Source: British Association for Psychopharmacology - BAP (Remove filter) Published by British Association for Psychopharmacology, 28 May 2012 These guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on their pharmacological management. They are based... Read Summary Type: Guidance (Remove filter)
Add this result to my export selection EUnetHTA Joint Action 3 WP4: Repetitive transcranial magnetic stimulation for treatment-resistant major depression (PDF) Source: EUnetHTA (Remove filter) Published by EUnetHTA, 24 April 2017 The purpose of the assessment is to examine the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in adult patients with treatment-resistant major depression. The... Read Summary Type: Health Technology Assessments (Remove filter)